Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

44.21
+1.082.50%
Post-market: 44.840.6300+1.43%19:43 EST
Volume:2.09M
Turnover:91.89M
Market Cap:11.85B
PE:18.60
High:44.44
Open:43.03
Low:42.96
Close:43.13
52wk High:49.62
52wk Low:31.90
Shares:268.11M
Float Shares:231.84M
Volume Ratio:0.71
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.38
EPS(LYR):1.80
ROE:30.56%
ROA:17.73%
PB:5.49
PE(LYR):24.60

Loading ...

Exelixis director buys $1.2M in common stock

TIPRANKS
·
15 hours ago

Exelixis Inc. Director David Edward Johnson Reports Acquisition of Common Shares

Reuters
·
15 hours ago

Exelixis Inc. Files Initial Statement of Beneficial Ownership for SVP and General Counsel Brenda Hefti

Reuters
·
Nov 21

Will Strong Q3 Results and $750M Buyback Shift Exelixis' (EXEL) Outlook?

Simply Wall St.
·
Nov 15

RBC Capital Keeps Their Hold Rating on Exelixis (EXEL)

TIPRANKS
·
Nov 14

A Fresh Look at Exelixis (EXEL) Valuation After Strong Earnings and New $750 Million Buyback

Simply Wall St.
·
Nov 14

Exelixis Inc. Director Stelios Papadopoulos Reports Disposal of Common Shares

Reuters
·
Nov 14

Exelixis EVP Dana Aftab Reports Disposal of Common Shares

Reuters
·
Nov 14

Exelixis Director Mary C. Beckerle Reports Sale of Common Shares

Reuters
·
Nov 14

Exelixis Announces Leadership Transition with New General Counsel

TIPRANKS
·
Nov 08

Exelixis Names Brenda Hefti as New General Counsel

Reuters
·
Nov 08

Exelixis Inc. to Present at Major Healthcare Investor Conferences

Reuters
·
Nov 07

Exelixis Is Maintained at Neutral by UBS

Dow Jones
·
Nov 07

UBS Adjusts Price Target on Exelixis to $40 From $35, Maintains Neutral Rating

MT Newswires Live
·
Nov 06

Exelixis (EXEL): Earnings Growth Accelerates to 72%, Reinforcing Bullish Market Narratives

Simply Wall St.
·
Nov 06

Exelixis Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Nov 06

Exelixis Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 06

Exelixis price target raised to $49 from $46 at H.C. Wainwright

TIPRANKS
·
Nov 06

Analysts’ Opinions Are Mixed on These Healthcare Stocks: PROCEPT BioRobotics (PRCT), Day One Biopharmaceuticals (DAWN) and Exelixis (EXEL)

TIPRANKS
·
Nov 06

Stock Track | Exelixis (EXEL) Soars 5.54% Pre-Market as Multiple Analysts Raise Price Targets

Stock Track
·
Nov 05